AINDEX
Markets

Organigram Global Inc. (OGI)

OGINASDAQ-GSBiotechnology: Pharmaceutical Preparations

$0.8560

-0.0200 (-2.28%) today

Regular session, Nov 10, 3:06 PM ET

-2.25% 1D
Market cap
$120.74m
P/E
–
EPS, last 4 quarters
$-0.2800
Dividend yield
–
Day range
$0.8500 to $0.8800
52-week range
$0.8531 to $2.24
Average volume
523.0k
Previous close
$0.8760

Analysts

2 covering

Buy2 buy, 0 hold, 0 sell

Targets a year out average $2.21, +158.2% from here

$2.12now $0.8560$2.30

Earnings

next estimate $0.0200

Next report Dec 15, 2026

Sep 2025

-1900.0%

Dec 2025

-100.0%

Mar 2026

0.0%

Jun 2026

-400.0%

estimate reported, and the surprise

Financials

No quarterly figures from the source.

News

8 latest

The company

Organigram Global Inc. is listed on the NASDAQ Global Select Market and TSX. The Company's wholly owned subsidiary, Organigram Inc. , is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH (' Sanity Group '), Organigram participates in the German medical cannabis market and other emerging markets within Europe . Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, Monjour, Tremblant, Collective Project , Trailblazer, BOXHOT and DEBUNK. Through its acquisition of Sanity Group , Organigram's European brands include Vayamed, avaay, ZOIKS, Endosane Pharmaceuticals , VAAY, and Grashaus Projects. Organigram operates facilities in Moncton, New Brunswick and Lac Superieur, Quebec , with a dedicated edibles manufacturing facility in Winnipeg, Manitoba .

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.